Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19

OpenAlex İngilizce

Coronavirus disease 2019 (COVID-19) is a global health problem, but optimal treatment modality is unclear. The treatment protocol for patients with COVID-19 consists of azithromycin, hydroxychloroquine (HCQ), and low-molecular-weight heparin in our center. Also, we prescribe oseltamivir until the return of influenza test results. Initially, HCQ was administered to all our patients for 5 days to 10 days (400 mg twice a day as a loading dose on the first day and then 200 mg twice a day as a maintenance dose for the next 4 to 9 days), without renal dose adjustments, according to the insufficient information at drug manufacturer's recommendations for short-term treatment.